-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 KOKP41RhAU7WJmgpLPmSWz+EQkqP/20g2Vlspi3W5N0/5jU6SsGeoIFCWLJOrcCK
 8qGZnHDRKYJ6uvCQ7LaVvA==

<SEC-DOCUMENT>0000950133-04-004788.txt : 20041229
<SEC-HEADER>0000950133-04-004788.hdr.sgml : 20041229
<ACCEPTANCE-DATETIME>20041229161704
ACCESSION NUMBER:		0000950133-04-004788
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20041229
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20041229
DATE AS OF CHANGE:		20041229

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UNITED THERAPEUTICS CORP
		CENTRAL INDEX KEY:			0001082554
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				521984749
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-26301
		FILM NUMBER:		041231343

	BUSINESS ADDRESS:	
		STREET 1:		1110 SPRING ST
		CITY:			SILVER SPRING
		STATE:			MD
		ZIP:			20910
		BUSINESS PHONE:		3016089292

	MAIL ADDRESS:	
		STREET 1:		1110 SPRING ST
		CITY:			SILVER SPRING
		STATE:			MD
		ZIP:			20910
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>w04198e8vk.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
<TITLE>e8vk</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<P align="center" style="font-size: 14pt"><B>SECURITIES AND EXCHANGE COMMISSION</B>

<DIV align="center" style="font-size: 12pt"><B>Washington, D.C. 20549</B>
</DIV>

<P align="center" style="font-size: 18pt"><B>FORM 8-K</B>


<P align="center" style="font-size: 12pt"><B>CURRENT REPORT<BR>
PURSUANT TO SECTION 13 OR 15(d) OF THE<BR>
SECURITIES EXCHANGE ACT OF 1934</B>



<P align="center" style="font-size: 10pt">Date of Report (Date of earliest event reported)<BR>
December&nbsp;29, 2004



<P align="center" style="font-size: 10pt"><HR size="1" noshade width="25%" align="center">


<P align="center" style="font-size: 24pt"><B>UNITED THERAPEUTICS CORPORATION</B>

<DIV align="center" style="font-size: 10pt">(Exact name of registrant as specified in its charter)</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>Delaware</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>000-26301</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>52-1984749</B></TD>
</TR>

<TR style="font-size: 1px">
    <TD align="center" valign="top"><HR size="1" noshade>&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><HR size="1" noshade>&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><HR size="1" noshade>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">(State or Other Jurisdiction<BR>
of Incorporation)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(Commission File Number)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(I.R.S. Employer<BR>
Identification No.)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><B>1110 Spring Street<BR>
Silver Spring, MD 20910</B><BR>
(Address of principal executive offices including Zip Code)



<P align="center" style="font-size: 10pt"><B>(301)&nbsp;608-9292</B>


<DIV align="center" style="font-size: 10pt"><HR size="1" noshade width="30%" align="center"></DIV>


<DIV align="center" style="font-size: 10pt">(Registrant&#146;s telephone number, including area code)</DIV>



<P align="center" style="font-size: 10pt"><B>N.A.</B>


<DIV align="center" style="font-size: 10pt"><HR size="1" noshade width="38%" align="center"></DIV>


<DIV align="center" style="font-size: 10pt">(Former name or former address, if changed since last report)</DIV>


<P align="left" style="font-size: 10pt">Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:



<P align="left" style="font-size: 10pt">&#091;&nbsp;&#093; Written communications pursuant to Rule&nbsp;425 under the Securities Act (17
CFR 230.425)



<P align="left" style="font-size: 10pt">&#091; &#093; Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR
240.14a-12)



<P align="left" style="font-size: 10pt">&#091; &#093; Pre-commencement communications pursuant to Rule&nbsp;14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))



<P align="left" style="font-size: 10pt">&#091; &#093; Pre-commencement communications pursuant to Rule&nbsp;13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))



<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<P align="left" style="font-size: 10pt"><B>Item&nbsp;1.01 Entry into a Material Definitive Agreement.</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Compensation Committee of the Board of Directors of United
Therapeutics Corporation (the &#147;Company&#148;) has approved amendments to the
following agreements of its named executive officers, effective December&nbsp;29,
2004: Executive Employment Agreement between Martine A. Rothblatt, Ph.D. and
the Company, dated April&nbsp;2, 1999, as previously amended (the &#147;<B><I>Rothblatt
Agreement</I></B>&#148;); Employment Agreement between Roger Jeffs, Ph.D. and the Company,
dated November&nbsp;29, 2000, as previously amended (the &#147;<B><I>Jeffs Agreement</I></B>&#148;);
Employment Agreement between Fred Hadeed and the Company, dated January&nbsp;3,
2000, as previously amended (the &#147;<B><I>Hadeed Agreement</I></B>&#148;); and the Employment
Agreement between Paul A. Mahon and the Company, dated June&nbsp;16, 2001, as
previously amended (the &#147;<B><I>Mahon Agreement</I></B>&#148;).


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Rothblatt Agreement has been amended to extend the stock option
exercise period upon termination, and to provide for the ability of Dr.
Rothblatt to take a senior advisor position with the Company upon termination,
as more particularly described in Exhibit&nbsp;10.1 hereto, which exhibit is
incorporated herein by reference. The Jeffs Agreement has been amended to
revise the term of that agreement, to revise the compensation upon termination
without cause provision, and to provide for the ability of Dr.&nbsp;Jeffs to take a
senior advisor position with the Company upon termination, as more particularly
described in Exhibit&nbsp;10.2 hereto, which exhibit is incorporated herein by
reference. The Hadeed Agreement has been amended to revise the term of the
agreement, to revise the compensation upon termination without cause provision,
and to provide for the ability of Mr.&nbsp;Hadeed to take a senior advisor position
with the Company upon termination, as more particularly described in Exhibit
10.3 hereto, which exhibit is incorporated herein by reference. The Mahon
Agreement has been amended to revise the compensation upon termination without
cause provision and to provide for the ability of Mr.&nbsp;Mahon to take a senior
advisor position with the Company upon termination, as more particularly
described in Exhibit&nbsp;10.4 hereto, which exhibit is incorporated herein by
reference.


<P align="left" style="font-size: 10pt"><B>Item&nbsp;9.01 Exhibits.</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Exhibits

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="4%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="90%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left"><B>Exhibit No.</B><HR size="1" noshade></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="Left"><B>Description of Exhibit</B><HR size="1" noshade></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="top">
    <TD><DIV style="margin-left:10px; text-indent:-10px">10.1</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Amendment to Executive Employment Agreement between Martine A. Rothblatt and United Therapeutics Corporation, dated April 2, 1999, as previously amended.</TD>
</TR>


<TR valign="top">
    <TD><DIV style="margin-left:10px; text-indent:-10px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD><DIV style="margin-left:10px; text-indent:-10px">10.2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Amendment to Employment Agreement between Roger Jeffs, Ph.D. and United Therapeutics Corporation dated November 29, 2000, as previously amended.</TD>
</TR>

<TR valign="top">
    <TD><DIV style="margin-left:10px; text-indent:-10px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD><DIV style="margin-left:10px; text-indent:-10px">10.3</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Amendment to Employment Agreement between Fred Hadeed and United Therapeutics Corporation dated January 3, 2000, as previously amended.</TD>
</TR>


<TR valign="top">
    <TD><DIV style="margin-left:10px; text-indent:-10px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD><DIV style="margin-left:10px; text-indent:-10px">10.4</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Amendment to Employment Agreement between Paul A. Mahon and United Therapeutics Corporation dated June 16, 2001, as previously amended.</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<P align="center" style="font-size: 10pt"><B>SIGNATURES</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="46%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><B>UNITED THERAPEUTICS CORPORATION</B><BR>
(Registrant)</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Dated: December&nbsp;29, 2004
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Paul A. Mahon</TD>
</TR>

<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><HR size="1" noshade>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Paul A. Mahon</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">General Counsel</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<P align="center" style="font-size: 10pt"><B>EXHIBIT INDEX</B>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="top">
    <TD width="4%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="90%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left"><B>Exhibit No.</B><HR size="1" noshade></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="Left"><B>Description of Exhibit</B><HR size="1" noshade></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="top">
    <TD><DIV style="margin-left:10px; text-indent:-10px">10.1</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Amendment to Executive Employment Agreement between Martine A. Rothblatt and United Therapeutics Corporation, dated April 2, 1999, as previously amended.</TD>
</TR>


<TR valign="top">
    <TD><DIV style="margin-left:10px; text-indent:-10px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD><DIV style="margin-left:10px; text-indent:-10px">10.2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Amendment to Employment Agreement between Roger Jeffs, Ph.D. and United Therapeutics Corporation dated November 29, 2000, as previously amended.</TD>
</TR>

<TR valign="top">
    <TD><DIV style="margin-left:10px; text-indent:-10px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD><DIV style="margin-left:10px; text-indent:-10px">10.3</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Amendment to Employment Agreement between Fred Hadeed and United Therapeutics Corporation dated January 3, 2000, as previously amended.</TD>
</TR>

<TR valign="top">
    <TD><DIV style="margin-left:10px; text-indent:-10px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="top">
    <TD><DIV style="margin-left:10px; text-indent:-10px">10.4</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Amendment to Employment Agreement between Paul A. Mahon and United Therapeutics Corporation dated June 16, 2001, as previously amended.</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

</BODY>
</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>w04198exv10w1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
<TITLE>exv10w1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<P align="right" style="font-size: 10pt">EXHIBIT 10.1



<P align="center" style="font-size: 10pt"><B>AMENDMENT</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;THIS AMENDMENT is made as of the 29th day of December&nbsp;2004 to the
Executive Employment Agreement between Martine A. Rothblatt (&#147;Executive&#148;) and
United Therapeutics Corporation dated April&nbsp;2, 1999, as previously amended (the
&#147;Agreement&#148;).


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, the parties desire to amend the Agreement as provided below.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NOW THEREFORE, for good and valuable consideration, the receipt and
sufficiency of which is hereby acknowledged, the parties hereby amend the
Agreement as follows:


<P align="left" style="font-size: 10pt">1. <u><B>Extension of Stock Option Exercise Period</B></u>. A new <u><I>Section&nbsp;4.2(g)</I></u> shall be
added to the Agreement as follows:



<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" nowrap align="right">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><u>Exercise Term of Stock Options</u>. The exercise period for each
stock option granted to Executive prior to Executive&#146;s Date
of Termination shall be the full remaining duration of the
term of each such option</TD>
</TR>

</TABLE>


<P align="left" style="font-size: 10pt">2. <u><B>Compensation Upon Termination Without Cause</B></u><B>. </B>A new <u><I>Section&nbsp;4.4</I></u> shall be
added to the Agreement as follows:



<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" nowrap align="right">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Notwithstanding any other provision of this Agreement to the
contrary, in the event that Executive chooses to resign for
any reason other than as result of a reason constituting
termination for Cause then, in such event, at the option of
the Executive, Executive may state in her letter of
resignation that she wishes to serve as a Senior Advisor to
the Company, which continuing service shall be on the
following terms: (i)&nbsp;Executive shall be employed on a
full-time basis as a Senior Advisor to the Company for up to
fifteen years from the date of resignation, for so long as
Executive is willing and able to provide advisory services to
the Company; (ii)&nbsp;Executive shall report to the Company&#146;s
General Counsel and shall at all times be diligent in
responding to informational or discussion requests and
project assignments from the General Counsel or his/her
designee; (iii)&nbsp;Executive shall receive compensation of
$50,000 per year without increase, bonus or other adjustment
for each year of service, payable semi-monthly or in such
other installments as shall be consistent with the Company&#146;s
payroll procedures, less all necessary withholding; (iv)
unless otherwise agreed to by the Company, Executive shall
provide such advisory services from Executive&#146;s personal
offices not located at Company facilities; (v)&nbsp;Executive
shall continue to abide by his or her obligations of
confidentiality and non-competition as provided in this
Agreement; and (vi)&nbsp;Executive shall receive compensation
termination as if Executive&#146;s employment had been terminated
without Cause.</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<P><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">



</TABLE>


<P align="left" style="font-size: 10pt">3. <u><B>Effect</B></u>. No other provisions of the Agreement shall be affected by this
Amendment, and all other provisions of the Agreement shall remain in full force
and effect.



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In witness whereof, the parties have executed this Amendment effective as
of the date first written above.

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="45%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="50%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">UNITED THERAPEUTICS CORPORATION</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Martine Rothblatt
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Roger A. Jeffs</TD>
</TR>

<TR style="font-size: 1px">
    <TD valign="top"><HR size="1" noshade><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><HR size="1" noshade>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Martine A. Rothblatt, Ph.D.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Roger Jeffs, Ph.D.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

</BODY>
</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>w04198exv10w2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<HTML>
<HEAD>
<TITLE>exv10w2</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<P align="right" style="font-size: 10pt">EXHIBIT 10.2



<P align="center" style="font-size: 10pt"><B>AMENDMENT</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;THIS AMENDMENT is made as of the 29th day of December&nbsp;2004 to the
Employment Agreement between Roger Jeffs, Ph.D. (&#147;Executive&#148;) and United
Therapeutics Corporation dated November&nbsp;29, 2000, as previously amended (the
&#147;Agreement&#148;).


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, the parties desire to amend the Agreement as provided below.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NOW THEREFORE, for good and valuable consideration, the receipt and
sufficiency of which is hereby acknowledged, the parties hereby amend the
Agreement as follows:


<P align="left" style="font-size: 10pt">1. <u><B>Term of the Agreement</B></u>. <u><I>Section&nbsp;2</I></u> of the Agreement presently provides as
follows:



<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" nowrap align="right">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><I>The employment of the Executive by the Company will commence
immediately upon the retirement of James W. Crow, Ph.D. from
his position as President and COO of the Company and end on
the fifth anniversary of such date (the &#147;Initial Term&#148;), and
thereafter shall continue from year to year for additional
one-year terms (the &#147;Additional Terms&#148;), unless and until
either party shall give notice of such party&#146;s intent to
terminate not less than 30&nbsp;days prior to the end of the
then-current Initial Term or Additional Term, which
termination shall be effective at the expiration of said
term, or until sooner terminated as hereinafter set forth.</I></TD>
</TR>

</TABLE>


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;The foregoing <u><I>Section&nbsp;2</I></u> provision shall be replaced in its entirety with the
following provision:



<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" nowrap align="right">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The employment of the Executive by the Company will commence
upon execution of this Agreement for a term of five (5)&nbsp;years
continuing to and including January&nbsp;31, 2010. The term (as
herein extended) shall automatically be extended by one (1)
additional year at the end of each year unless at least six
(6)&nbsp;months prior to the end of the term or any anniversary
thereof, the Company shall deliver to Executive or Executive
shall deliver to the Company written notice that the term
shall not be so extended.</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<P><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">



</TABLE>


<P align="left" style="font-size: 10pt">2. <u><B>Compensation Upon Termination Without Cause</B></u>. <u><I>Section&nbsp;8(d)</I></u> of the Agreement
presently provides as follows:



<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" nowrap align="right">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><I>If (i)&nbsp;the Company terminates the Executive&#146;s employment
without Cause, or (ii)&nbsp;the Executive&#146;s employment is
terminated as a result of the transfer of control of the
Company by acquisition, merger, hostile takeover or for any
other reason whatsoever, or (iii)&nbsp;Executive&#146;s authority and
responsibilities are materially diminished without cause
relating to the performance of Executive&#146;s services hereunder
and Executive terminates this Agreement as a result of such
unjustified diminution of authority, then should any of the
foregoing events occur, the Company shall pay to Executive a
lump-sum amount equal to the amount Executive would have been
entitled to receive in Base Salary for the time remaining in
Executive&#146;s then current term of employment (either Initial
Term or Additional Term), or 2 times the Executive&#146;s then
current salary, whichever is greater. Such payment shall be
fully due and payable to Executive in a lump sum upon
Executive&#146;s Date of Termination. Additionally, in the event
of termination contemplated in this Section&nbsp;</I><I>8(d)</I><I>, all options
granted to Executive pursuant to </I><I>Section 4(c)</I><I> shall
immediately vest in Executive.</I></TD>
</TR>

</TABLE>


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;The foregoing <u><I>Section&nbsp;8(d)</I></u> provision shall be replaced in its entirety with
the following provision:



<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" nowrap align="right">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>If (i)&nbsp;the Company terminates Executive&#146;s employment without
Cause, or (ii)&nbsp;the Executive&#146;s employment is terminated as a
result of the transfer of control of the Company by
acquisition, merger, hostile takeover or for any other reason
whatsoever, or (iii)&nbsp;Executive&#146;s authority and
responsibilities are materially diminished without cause
relating to the performance of Executive&#146;s services hereunder
and Executive terminates this Agreement as a result of such
unjustified diminution of authority, then should any of the
foregoing events occur, the Company shall pay to Executive a
lump-sum amount equal to two times (i)&nbsp;Executive&#146;s current
annual rate of Base Salary, plus (ii)&nbsp;the greater of the
bonus and/or other incentive payments awarded to executive
for the immediately preceding year or the average bonus
and/or other inventive payments awarded to the Executive for
the previous two years. Such payment shall be fully due and
payable to Executive in a lump sum upon Executive&#146;s Date of
Termination. Additionally, in the event of termination
contemplated in this Section&nbsp;8(d), all unvested options
granted to Executive prior to Executive&#146;s Date of Termination
shall immediately vest in Executive upon Executive&#146;s Date of
Termination, and the exercise period for each such
previously-granted option shall be the full remaining
duration of the term of each such option.</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<P><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">



</TABLE>


<P align="left" style="font-size: 10pt">3. <u><B>Compensation Upon Termination Without Cause</B></u>. A new <u><I>Section&nbsp;8(e)</I></u> shall be
added to the Agreement as follows:



<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" nowrap align="right">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Notwithstanding any other provision of this Agreement to the
contrary, in the event that Executive chooses to resign for
any reason other than as result of a reason constituting
termination for Cause then, in such event, at the option of
the Executive, Executive may state in his letter of
resignation that he wishes to serve as a Senior Advisor to
the Company, which continuing service shall be on the
following terms: (i)&nbsp;Executive shall be employed on a
full-time basis as a Senior Advisor to the Company for up to
fifteen years from the date of resignation, for so long as
Executive is willing and able to provide advisory services to
the Company; (ii)&nbsp;Executive shall report to the Company&#146;s
General Counsel and shall at all times be diligent in
responding to informational or discussion requests and
project assignments from the General Counsel or his/her
designee; (iii)&nbsp;Executive shall receive compensation of
$50,000 per year without increase, bonus or other adjustment
for each year of service, payable semi-monthly or in such
other installments as shall be consistent with the Company&#146;s
payroll procedures, less all necessary withholding; (iv)
unless otherwise agreed to by the Company, Executive shall
provide such advisory services from
Executive&#146;s personal offices not located at Company
facilities; (v)&nbsp;Executive shall continue to abide by his or
her obligations of confidentiality and non-competition as
provided in this Agreement; and (vi)&nbsp;Executive shall receive
compensation termination as if Executive&#146;s employment had
been terminated without Cause.</TD>
</TR>

</TABLE>


<P align="left" style="font-size: 10pt">4. <u> <B>Effect</B></u>. No other provisions of the Agreement shall be affected by this
Amendment, and all other provisions of the Agreement shall remain in full force
and effect.



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In witness whereof, the parties have executed this Amendment effective as
of the date first written above.

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="35%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">UNITED THERAPEUTICS CORPORATION</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Roger A. Jeffs
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Martine Rothblatt</TD>
</TR>

<TR style="font-size: 1px">
    <TD valign="top"><HR size="1" noshade><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><HR size="1" noshade width="76%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Roger Jeffs, Ph.D.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Martine A. Rothblatt, Ph.D.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

</BODY>
</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>w04198exv10w3.htm
<DESCRIPTION>EXHIBIT 10.3
<TEXT>
<HTML>
<HEAD>
<TITLE>exv10w3</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<P align="right" style="font-size: 10pt">EXHIBIT 10.3



<P align="center" style="font-size: 10pt"><B>AMENDMENT</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;THIS AMENDMENT is made as of the 29th day of December&nbsp;2004 to the
Employment Agreement between Fred Hadeed (&#147;Executive&#148;) and United Therapeutics
Corporation dated January&nbsp;3, 2000, as previously amended (the &#147;Agreement&#148;).


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, the parties desire to amend the Agreement as provided below.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NOW THEREFORE, for good and valuable consideration, the receipt and
sufficiency of which is hereby acknowledged, the parties hereby amend the
Agreement as follows:


<P align="left" style="font-size: 10pt">1. <u><B>Term of the Agreement</B></u>. <u><I>Section&nbsp;3</I></u> of the Agreement presently provides as
follows:



<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" nowrap align="right">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><I>The employment of the Executive by United Therapeutics will
commence on January&nbsp;31, 2000 and end on the second
anniversary of such date (the &#147;Initial Term&#148;), and thereafter
shall continue for two additional two-year terms (the
&#147;Additional Terms&#148;), unless and until either party shall give
notice of such party&#146;s intent to terminate not less than 60
days prior to the end of the then-current Initial Term or
Additional Term, which termination shall be effective at the
expiration of said term, or until sooner terminated as
hereinafter set forth.</I></TD>
</TR>

</TABLE>


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;The foregoing <u><I>Section&nbsp;3</I></u> provision shall be replaced in its entirety with the
following provision:



<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" nowrap align="right">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The employment of the Executive by the Company will commence
on execution of this Agreement for a term of five (5)&nbsp;years
continuing to and including January&nbsp;31, 2005. The term (as
herein extended) shall automatically be extended by one (1)
additional year at the end of each year unless at least six
(6)&nbsp;months prior to the end of the term or any anniversary
thereof, the Company shall deliver to Executive or Executive
shall deliver to the Company written notice that the term
shall not be so extended.</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<P><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">



</TABLE>


<P align="left" style="font-size: 10pt">2.&nbsp;<u><B>Compensation Upon Termination Without Cause</B></u>. <u><I>Section&nbsp;9(e</I></u><I>) </I>of the Agreement
presently provides as follows:


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" nowrap align="right">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><I>If (i)&nbsp;the Company terminates Executive&#146;s employment without
Cause, or (ii)&nbsp;the Executive&#146;s employment is terminated as a
result of the transfer of control of the Company by
acquisition, merger, hostile takeover or for any other reason
whatsoever, or (iii)&nbsp;Executive&#146;s authority and
responsibilities are materially diminished without cause
relating to the performance of Executive&#146;s services hereunder
and Executive terminates this Agreement as a result of such
unjustified diminution of authority, then should any of the
foregoing events occur, the Company shall pay to Executive a
lump-sum amount equal to the greater of either: (a)&nbsp;the
amount Executive would have been
entitled to receive in current Base Salary for the time
remaining in Executive&#146;s then current term of employment, or
(b)&nbsp;an amount equal to two years of current Base Salary.
Such payment shall be fully due and payable to Executive in a
lump sum upon Executive&#146;s Date of Termination. Additionally,
in the event of termination contemplated in this Section
8(e), all options granted to Executive shall immediately vest
in Executive.</I></TD>
</TR>

</TABLE>


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;The foregoing <u><I>Section&nbsp;9(e)</I></u> provision shall be replaced in its entirety with
the following provision:



<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" nowrap align="right">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>If (i)&nbsp;the Company terminates Executive&#146;s employment without
Cause, or (ii)&nbsp;the Executive&#146;s employment is terminated as a
result of the transfer of control of the Company by
acquisition, merger, hostile takeover or for any other reason
whatsoever, or (iii)&nbsp;Executive&#146;s authority and
responsibilities are materially diminished without cause
relating to the performance of Executive&#146;s services hereunder
and Executive terminates this Agreement as a result of such
unjustified diminution of authority, then should any of the
foregoing events occur, the Company shall pay to Executive a
lump-sum amount equal to two times (i)&nbsp;Executive&#146;s current
annual rate of Base Salary, plus (ii)&nbsp;the greater of the
bonus and/or other incentive payments awarded to executive
for the immediately preceding year or the average bonus
and/or other inventive payments awarded to the Executive for
the previous two years. Such payment shall be fully due and
payable to Executive in a lump sum upon Executive&#146;s Date of
Termination. Additionally, in the event of termination
contemplated in this Section&nbsp;8(d), all unvested options
granted to Executive prior to Executive&#146;s Date of Termination
shall immediately vest in Executive upon Executive&#146;s Date of
Termination, and the exercise period for each such
previously-granted option shall be the full remaining
duration of the term of each such option.</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<P><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">



</TABLE>


<P align="left" style="font-size: 10pt">3. <u><B>Compensation Upon Termination Without Cause</B></u>. A new <u><I>Section&nbsp;9(f)</I></u> shall be
added to the Agreement as follows:



<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" nowrap align="right">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Notwithstanding any other provision of this Agreement to the
contrary, in the event that Executive chooses to resign for
any reason other than as result of a reason constituting
termination for Cause then, in such event, at the option of
the Executive, Executive may state in his letter of
resignation that he wishes to serve as a Senior Advisor to
the Company, which continuing service shall be on the
following terms: (i)&nbsp;Executive shall be employed on a
full-time basis as a Senior Advisor to the Company for up to
fifteen years from the date of resignation, for so long as
Executive is willing and able to provide advisory services to
the Company; (ii)&nbsp;Executive shall report to the Company&#146;s
General Counsel and shall at all times be diligent in
responding to informational or discussion requests and
project assignments from the General Counsel or his/her
designee; (iii)&nbsp;Executive shall receive compensation of
$50,000 per year without increase, bonus or other adjustment
for each year of service, payable semi-monthly or in such
other installments as shall be consistent with the Company&#146;s
payroll procedures, less all necessary withholding; (iv)
unless otherwise agreed to by the Company, Executive shall
provide such advisory services from Executive&#146;s personal
offices not located at Company facilities; (v)&nbsp;Executive
shall continue to abide by his or her obligations of
confidentiality and non-competition as provided in this
Agreement; and (vi)&nbsp;Executive shall receive compensation
termination as if Executive&#146;s employment had been terminated
without Cause.</TD>
</TR>

</TABLE>


<P align="left" style="font-size: 10pt">4. <u><B>Effect</B></u>. No other provisions of the Agreement shall be affected by this
Amendment, and all other provisions of the Agreement shall remain in full force
and effect.



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In witness whereof, the parties have executed this Amendment effective as
of the date first written above.

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="31%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="64%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">UNITED THERAPEUTICS CORPORATION</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Fred Hadeed
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Martine Rothblatt</TD>
</TR>

<TR style="font-size: 1px">
    <TD valign="top"><HR size="1" noshade><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><HR size="1" noshade width="65%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Fred Hadeed
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Martine A. Rothblatt</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

</BODY>
</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>w04198exv10w4.htm
<DESCRIPTION>EXHIBIT 10.4
<TEXT>
<HTML>
<HEAD>
<TITLE>exv10w4</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<P align="right" style="font-size: 10pt">EXHIBIT 10.4



<P align="center" style="font-size: 10pt"><B>AMENDMENT</B>



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;THIS AMENDMENT is made as of the 29th day of December&nbsp;2004 to the
Employment Agreement between Paul A. Mahon (&#147;Executive&#148;) and United
Therapeutics Corporation dated June&nbsp;16, 2001, as previously amended (the
&#147;Agreement&#148;).


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, the parties desire to amend the Agreement as provided below.


<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NOW THEREFORE, for good and valuable consideration, the receipt and
sufficiency of which is hereby acknowledged, the parties hereby amend the
Agreement as follows:


<P align="left" style="font-size: 10pt">1. <u><B>Compensation Upon Termination Without Cause</B></u>. <u><I>Section&nbsp;8(d</I></u><I>) </I>of the Agreement
presently provides as follows:



<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" nowrap align="right">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><I>If (i)&nbsp;the Company terminates the Executive&#146;s employment
without Cause, or (ii)&nbsp;the Executive&#146;s employment is
terminated as a result of the transfer of control of the
Company by acquisition, merger, hostile takeover or for any
other reason whatsoever, or (iii)&nbsp;Executive&#146;s authority and
responsibilities are materially diminished without cause
relating to the performance of Executive&#146;s services hereunder
and Executive terminates this Agreement as a result of such
unjustified diminution of authority, then should any of the
foregoing events occur, the Company shall pay to Executive a
lump-sum amount equal to the greater of either: (a)&nbsp;the
amount Executive would have been entitled to receive in Base
Salary for the time remaining in Executive&#146;s then current
term of employment, or (b)&nbsp;an amount equal to two years of
Base Salary. Such payment shall be fully due and payable to
Executive in a lump sum upon Executive&#146;s Date of Termination.
Additionally, in the event of termination contemplated in
this Section&nbsp;</I><I>8(d)</I><I>, all options granted to Executive pursuant
to </I><I>Section 4(c)</I><I> shall immediately vest in Executive.</I></TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<P><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">



</TABLE>


<P align="left" style="font-size: 10pt">The foregoing <u><I>Section&nbsp;8(d)</I></u> provision shall be replaced in its entirety with the
following provision:



<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" nowrap align="right">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>If (i)&nbsp;the Company terminates the Executive&#146;s employment
without Cause, or (ii)&nbsp;the Executive&#146;s employment is
terminated as a result of the transfer of control of the
Company by acquisition, merger, hostile takeover or for any
other reason whatsoever, or (iii)&nbsp;Executive&#146;s authority and
responsibilities are materially diminished without cause
relating to the performance of Executive&#146;s services hereunder
and Executive terminates this Agreement as a result of such
unjustified diminution of authority, then should any of the
foregoing events occur, the Company shall pay to Executive a
lump-sum amount equal to two times (i)&nbsp;Executive&#146;s current
annual rate of Base Salary, plus (ii)&nbsp;the greater of the
bonus and/or other incentive payments awarded to executive
for the immediately preceding year or the average bonus
and/or other inventive payments awarded to the Executive for
the previous two years. Such payment shall be fully due and
payable to Executive in a lump sum upon Executive&#146;s Date of
Termination. Additionally, in the event of termination
contemplated in this
Section&nbsp;8(d), all unvested options granted to Executive prior
to Executive&#146;s Date of Termination shall immediately vest in
Executive upon Executive&#146;s Date of Termination, and the
exercise period for each such previously-granted option shall
be the full remaining duration of the term of each such
option.</TD>
</TR>

</TABLE>


<P align="left" style="font-size: 10pt">2. <u><B>Compensation Upon Termination Without Cause</B></u>. A new <u><I>Section&nbsp;8(e)</I></u> shall be
added to the Agreement as follows:



<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="6%" nowrap align="right">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Notwithstanding any other provision of this Agreement to the
contrary, in the event that Executive chooses to resign for
any reason other than as result of a reason constituting
termination for Cause then, in such event, at the option of
the Executive, Executive may state in his letter of
resignation that he wishes to serve as a Senior Advisor to
the Company, which continuing service shall be on the
following terms: (i)&nbsp;Executive shall be employed on a
full-time basis as a Senior Advisor to the Company for up to
fifteen years from the date of resignation, for so long as
Executive is willing and able to provide advisory services to
the Company; (ii)&nbsp;Executive shall report to the Company&#146;s
General Counsel and shall at all times be diligent in
responding to informational or discussion requests and
project assignments from the General Counsel or his/her
designee; (iii)&nbsp;Executive shall receive compensation of
$50,000 per year without increase, bonus or other adjustment
for each year of service, payable semi-monthly or in such
other installments as shall be consistent with the Company&#146;s
payroll procedures, less all necessary withholding; (iv)
unless otherwise agreed to by the Company, Executive shall
provide such advisory services from Executive&#146;s personal
offices not located at Company facilities; (v)&nbsp;Executive
shall continue to abide by his or her obligations of
confidentiality and non-competition as provided in this
Agreement; and (vi)&nbsp;Executive shall receive compensation
termination as if Executive&#146;s employment had been terminated
without Cause.</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<P><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">



</TABLE>


<P align="left" style="font-size: 10pt">3. <u><B>Effect</B></u>. No other provisions of the Agreement shall be affected by this
Amendment, and all other provisions of the Agreement shall remain in full force
and effect.



<P align="left" style="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In witness whereof, the parties have executed this Amendment effective as
of the date first written above.

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="29%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="66%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">UNITED THERAPEUTICS CORPORATION</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Paul Mahon
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Martine Rothblatt</TD>
</TR>

<TR style="font-size: 1px">
    <TD valign="top"><HR size="1" noshade><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><HR size="1" noshade width="65%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Paul A. Mahon
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Martine A. Rothblatt</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>




<P align="center" style="font-size: 10pt">&nbsp;
</DIV>


</BODY>
</HTML>

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
